Gender Differences in Clinical Outcomes After Percutaneous Coronary Interventions With Zotarolimus-Eluting Stents: Insights From the Korean Endeavor Registry
- Authors
- Song, PS[Song, Pil Sang]; Song, YB[Song, Young Bin]; Hahn, JY[Hahn, Joo-Yong]; Kim, DI[Kim, Doo-Il]; Yang, JH[Yang, Jeong Hoon]; Choi, SH[Choi, Seung-Hyuk]; Choi, JH[Choi, Jin-Ho]; Gwon, HC[Gwon, Hyeon-Cheol]
- Issue Date
- Dec-2013
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Keywords
- Gender; Percutaneous transluminal coronary angioplasty; Drug-eluting stent
- Citation
- AMERICAN JOURNAL OF THE MEDICAL SCIENCES, v.346, no.6, pp.479 - 485
- Indexed
- SCIE
SCOPUS
- Journal Title
- AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Volume
- 346
- Number
- 6
- Start Page
- 479
- End Page
- 485
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/58280
- DOI
- 10.1097/MAJ.0b013e318297bd98
- ISSN
- 0002-9629
- Abstract
- Background:The impact of gender on outcomes after percutaneous coronary intervention (PCI) with second-generation drug-eluting stents is not known in Asian patients. The authors studied outcomes after PCI with zotarolimus-eluting stent in unselected consecutive series of Asian patients according to gender.Methods:Outcomes among patients treated with zotarolimus-eluting stents from multicenter registry were evaluated by gender. The primary outcome was major adverse cardiac events, composite of cardiac death, myocardial infarction and target lesion revascularization at 1 year.Results:Of 2,840 patients, 855 (30.1%) were women. Comparatively, women were older; more frequently had diabetes, hypertension, and dyslipidemia; less frequently women were current smokers, had previous myocardial infarctions and previous PCIs; were more likely to have culprit lesions in left anterior descending coronary artery; and underwent more multilesion PCIs. After adjustment for baseline differences, women were still at lower risk of major adverse cardiac events (38 [4.4%] versus 137 [6.9%], adjusted hazard ratio [HR]: 0.52, 95% confidence interval [CI]: 0.30-0.89, P = 0.018), mainly driven by target lesion revascularization (24 [2.8%] versus 106 [5.3%], adjusted HR: 0.41, 95% CI: 0.24-0.70, P = 0.001) at 1 year, although rates of cardiac death, myocardial infarction and stent thrombosis were similar between genders. These results were consistent after propensity score-matched population analysis (for major adverse cardiac events, adjusted HR: 0.36, 95% CI: 0.18-0.69, P = 0.012; for target lesion revascularization, adjusted HR: 0.32, 95% CI: 0.15-0.69, P = 0.004) and were also constant among various high-risk subgroups.Conclusions:Despite greater baseline clinical and angiographic risk, the use of the zotarolimus-eluting stent is associated with favorable outcomes among Asian women treated with PCI.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/58280)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.